Latest Global Distribution News

Page 2 of 6
Tetratherix Limited reported a $4.6 million statutory loss for the first half of FY26, driven by increased R&D and manufacturing investments, while making significant progress in clinical trials and securing key global partnerships.
Ada Torres
Ada Torres
24 Feb 2026
Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.
Ada Torres
Ada Torres
24 Feb 2026
EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.
Victor Sage
Victor Sage
17 Feb 2026
Aumake Limited has secured a four-year exclusive global distribution agreement with EZZ Life Sciences, targeting $10 million in sales and expanding its footprint in high-margin nutraceuticals.
Victor Sage
Victor Sage
17 Feb 2026
Nanoveu Limited has raised A$7.5 million through a strategic placement to accelerate the commercial rollout of its cutting-edge EMASS ECS-DoT semiconductor technology, including a rapid 16nm chip tape-out and live drone validation.
Sophie Babbage
Sophie Babbage
20 Jan 2026
Orthocell Limited has reported a record $3.2 million revenue for the December 2025 quarter, marking its seventh consecutive quarter of growth, fuelled by expanding sales of its nerve repair product Remplir in the US and other international markets.
Ada Torres
Ada Torres
19 Jan 2026
Tetratherix has inked a global exclusive distribution agreement with healthcare giant Henry Schein, paving the way for its first bone regeneration product, Tegenix, to enter major markets in 2026. Concurrently, the company has begun building an advanced manufacturing facility to meet expected global demand.
Ada Torres
Ada Torres
19 Jan 2026
Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.
Ada Torres
Ada Torres
16 Jan 2026
Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.
Ada Torres
Ada Torres
12 Jan 2026
Ava Risk Group’s BQT Solutions has inked a five-year supply and co-development agreement with US-based UniKey Technologies, targeting the booming mobile credential access market with new NFC/BLE readers.
Sophie Babbage
Sophie Babbage
2 Dec 2025
DroneShield Limited reaffirms strong business fundamentals with record revenues in 2025, while addressing recent media reports and initiating an independent governance review.
Sophie Babbage
Sophie Babbage
24 Nov 2025
Australian Agricultural Company Limited (AACo) reported a record first-half operating profit of $39.8 million, boosted by higher beef and cattle prices and volumes, alongside strategic investments in feedlot expansion and carbon projects.
Ada Torres
Ada Torres
20 Nov 2025